Skip to main navigation Skip to search Skip to main content

Gastrointestinal and liver manifestations in patients with COVID-19

Research output: Contribution to journalReview articlepeer-review

157 Scopus citations

Abstract

As the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread over the world, the World Health Organization has declared the outbreak of COVID-19 an international public health emergency. Besides typical respiratory symptoms and signs of COVID-19, digestive symptoms and liver injury have been frequently reported during the course of the disease. In this review, we summarized the recent studies reporting of gastrointestinal and liver manifestations during the course of COVID-19. Digestive symptoms, including anorexia, nausea, vomiting, and diarrhea, are not uncommon in patients with COVID-19, and in some cases digestive symptoms may occur in the absence of any respiratory symptoms. Furthermore, SARS-CoV-2 could be detected in the stool of infected patients, implicating the possibility of fecal–oral transmission. Attention should also be paid to monitor liver function during the course of COVID-19, especially in patients with higher disease severity.

Original languageEnglish
Pages (from-to)521-523
Number of pages3
JournalJournal of the Chinese Medical Association
Volume83
Issue number6
DOIs
StatePublished - Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Digestive
  • Gastrointestinal
  • Liver
  • Severe acute respiratory syndrome coronavirus 2

Fingerprint

Dive into the research topics of 'Gastrointestinal and liver manifestations in patients with COVID-19'. Together they form a unique fingerprint.

Cite this